Skip to main content

Table 4 Comparison of segmental and global ECV

From: Cardiac profile of the Czech population of Duchenne muscular dystrophy patients: a cardiovascular magnetic resonance study with T1 mapping

Segment Group C
(Controls)
n = 13
Group D1
(LGE–)
n = 23
Group D2
(LGE+)
n = 20
p (C vs. D1) p (C vs. D2) p (D1 vs. D2)
crude age-adjusted crude age-adjusted crude age-adjusted
Anterior 0.243 ± 0.017 0.258 ± 0.030 0.266 ± 0.046 0.50 0.50 0.21 0.22 0.76 0.76
Anteroseptal 0.252 ± 0.015 0.258 ± 0.029 0.265 ± 0.057 0.93 0.93 0.69 0.69 0.83 0.83
Inferoseptal 0.251 ± 0.014 0.251 ± 0.030 0.264 ± 0.052 1.00 1.00 0.63 0.62 0.52 0.51
Inferior* 0.237 ± 0.015 0.252 ± 0.029 0.271 ± 0.045 0.50 0.51 0.033 0.035 0.18 0.18
Inferolateral* 0.236 ± 0.015 0.250 ± 0.031 0.338 ± 0.076 0.75 0.76 1.10 −4 1.10 − 4 1.10 − 4 1.10 − 4
Anterolateral* 0.236 ± 0.016 0.251 ± 0.031 0.296 ± 0.066 0.65 0.65 0.003 0.003 0.008 0.008
Global* 0.243 ± 0.013 0.253 ± 0.028 0.280 ± 0.044 0.71 0.71 0.015 0.015 0.031 0.031
  1. Variables are expressed as the mean ± standard deviation. Variables marked in bold and denoted with * have their ANOVA p-value < 0.05
  2. P-values of the post hoc tests < 0.05 are marked in bold
  3. ECV extracellular volume, LGE– negative late gadolinium enhancement, LGE+ positive late gadolinium enhancement